ask="10.80"
ask_size="200"
average_daily_volume="248460"
bid="9.06"
bid_size="200"
book_value="2.66"
change="+0.09"
change_from_200_day_moving_average="1.62"
change_from_50_day_moving_average="0.50"
change_from_52_week_high="-0.56"
change_From_52_week_low="3.51"
change_in_percent="+0.86%"
close="10.51"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-3.30"
ebitda="-117.58M"
eps_estimate_current_year="-2.03"
eps_estimate_next_quarter="-0.30"
eps_estimate_next_year="-1.73"
ex_dividend_date="N/A"
float_shares="15511000"
high="10.60"
high_52_weeks="11.07"
last_trade_date="2/16/2017"
last_trade_price="10.51"
last_trade_size="8389"
last_trade_time="4:00pm"
low="10.22"
low_52_weeks="7.00"
market_capitalization="192.33M"
moving_average_200_day="8.89"
moving_average_50_day="10.01"
name="Akebia Therapeutics
Inc."
notes="N/A"
one_year_target_price="16.00"
open="10.46"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+18.20%"
percent_change_from_50_day_moving_average="+4.99%"
percent_change_from_52_week_high="-5.06%"
percent_change_from_52_week_low="+50.14%"
previous_close="10.42"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.92"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="18300000"
short_ratio="7.05"
stock_exchange="NGM"
symbol="AKBA"
volume="228104"
weeks_range_52="7.00 - 11.07"
